BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vierling JM. Management of HBV Infection in Liver Transplantation Patients. Int J Med Sci 2005;2:41-9. [PMID: 15968339 DOI: 10.7150/ijms.2.41] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Zoulim F. Emerging drugs for hepatitis B. Expert Opin Emerg Drugs 2007;12:199-217. [PMID: 17604497 DOI: 10.1517/14728214.12.2.199] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
2 Dindoost P, Jazayeri SM, Alavian SM. Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update. Hepat Mon 2012;12:168-76. [DOI: 10.5812/hepatmon.5124] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mas A, Castells L, Abradelo M, Bernardos Á, Páez A, Woodward M, Sousa J. Evaluation of Anti-HBs Serum Levels and Pharmacokinetic Profile After Intravenous Administration of Niuliva, a New Hepatitis B Immunoglobulin, Following Liver Transplantation. Transplantation Proceedings 2009;41:4253-8. [DOI: 10.1016/j.transproceed.2009.09.083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
4 Akyildiz M, Karasu Z, Zeytunlu M, Aydin U, Ozacar T, Kilic M. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis. J Gastroenterol Hepatol. 2007;22:2130-2134. [PMID: 18031370 DOI: 10.1111/j.1440-1746.2006.04609.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
5 Freshwater DA, Dudley T, Cane P, Mutimer DJ. Viral persistence after liver transplantation for hepatitis B virus: a cross-sectional study. Transplantation. 2008;85:1105-1111. [PMID: 18431229 DOI: 10.1097/tp.0b013e31816a342a] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
6 Shen ZY, Zheng WP, Deng YL, Song HL. Variations in the S and P regions of the hepatitis B virus genome under immunosuppression in vitro and in vivo. Viral Immunol. 2012;25:368-378. [PMID: 22946668 DOI: 10.1089/vim.2012.0008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
7 Schreibman IR, Schiff ER. Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues. Ann Clin Microbiol Antimicrob 2006;5:8. [PMID: 16600049 DOI: 10.1186/1476-0711-5-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
8 Bayliss J, Lim L, Thompson AJ, Desmond P, Angus P, Locarnini S, Revill PA. Hepatitis B virus splicing is enhanced prior to development of hepatocellular carcinoma. J Hepatol. 2013;59:1022-1028. [PMID: 23811301 DOI: 10.1016/j.jhep.2013.06.018] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
9 Choi HJ, Kim DG, Kim SI, Wang HJ, Joh JW, Suh KS, Kim SH. A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B. Ann Transplant 2017;22:740-8. [PMID: 29229898 DOI: 10.12659/aot.905898] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Olivera-Martínez MA, Gallegos-Orozco JF. Recurrent viral liver disease (hepatitis B and C) after liver transplantation. Arch Med Res 2007;38:691-701. [PMID: 17613360 DOI: 10.1016/j.arcmed.2006.09.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
11 Almeida RA, Silva GF, Llanos JC, Winckler CC, Gomes MR, Biagioni DS, Paula RC, Meira DA, Bakonyi A. Serologic profile in hepatitis B virus and hepatitis C virus in a Brazilian liver transplant waiting list. Transplant Proc 2006;38:1920-1. [PMID: 16908323 DOI: 10.1016/j.transproceed.2006.06.060] [Reference Citation Analysis]
12 Singham J, Greanya ED, Lau K, Erb SR, Partovi N, Yoshida EM. Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence†. Annals of Hepatology 2010;9:166-71. [DOI: 10.1016/s1665-2681(19)31656-4] [Cited by in Crossref: 29] [Article Influence: 2.4] [Reference Citation Analysis]
13 Vierling JM. The immunology of hepatitis B. Clin Liver Dis. 2007;11:727-759, vii-viii. [PMID: 17981227 DOI: 10.1016/j.cld.2007.08.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
14 Montalbano M, Neff GW. Management of recurrent viral hepatitis B and C after liver transplantation. Curr Gastroenterol Rep 2006;8:60-6. [PMID: 16510036 DOI: 10.1007/s11894-006-0065-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Sugawara Y, Makuuchi M. Liver transplantation for hepatitis B-related cirrhosis: recent advances. J Hepatobiliary Pancreat Surg. 2006;13:378-381. [PMID: 17013710 DOI: 10.1007/s00534-005-1077-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
16 Dindoost P, Jazayeri SM, Alavian SM. Hepatitis B immune globulin in liver transplantation prophylaxis: an update. Hepat Mon. 2012;12:168-176. [PMID: 22550524 DOI: 10.5812/hepatmon.832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
17 Saab S, Desai S, Tsaoi D, Durazo F, Han S, McClune A, Holt C, Farmer D, Goldstein L, Busuttil RW. Posttransplantation hepatitis B prophylaxis with combination oral nucleoside and nucleotide analog therapy. Am J Transplant. 2011;11:511-517. [PMID: 21299826 DOI: 10.1111/j.1600-6143.2010.03416.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]